TG4001 – Regulatory clearance received for randomized Phase II trial – First patient expected to be enrolled in 2Q 2021
TG6002 – Initial Phase I data provides clinical proof of concept for the intravenous administration of Transgene’s double deleted VVcopTK-RR- patented virus backbone, the basis of the Invir.IO™
Credit: Pixabay/CC0 Public Domain In 2018, industry and academic researchers revealed a potentially devastating hardware flaw that made computers and other devices worldwide vulnerable to...
Kansas City-Style Grilled Oysters Fire, flame and food is a primitive craving, and Small’s Smokehouse + Oyster Bar in Norfolk, Virginia, applies that practice to...
During the pandemic, Milwaukee shut down most organized sports for kids. “You couldn't use parks, you couldn't use gyms, you couldn't use school facilities,” said...
Does it go fast and is it fun - automotive-wise? Not exactly... The UK government is to allow vehicles equipped with a degree of automated...
Style and utility, health and fitness, mind and body — all connected by GarminGarmin® International, Inc., a unit of Garmin Ltd. (NASDAQ: GRMN), today announced...
Sheriff Ed Troyer told a 911 dispatcher on the night of Jan. 27 that a Black newspaper carrier had threatened to kill him, a statement...